Fibrinolytic response during exercise and epinephrine infusion in the same subjects

Department of Laboratory Medicine, University of Washington, Seattle 98195.

To determine whether exercise-induced increases in tissue plasminogen activator (t-PA) were related to plasma epinephrine concentration during exercise, 14 healthy men (aged 24 to 62 years) were studied during epinephrine infusions (10, 25 and 50 ng/kg per min) and graded supine bicycle exercise, beginning at 33 W and increasing in 33-W increments until exhaustion. Plasma epinephrine, active and total t-PA, active plasminogen activator inhibitor type 1 (PAI-1) and t-PA/PAI-1 complex concentrations were measured at each exercise and infusion level. During epinephrine infusion, active and total t-PA levels increased linearly with the plasma epinephrine concentration (respective slopes [+/- SEM] of 0.062 +/- 0.003 and 0.076 +/- 0.003 pmol/ng epinephrine). During exercise, t-PA levels did not increase until plasma epinephrine levels increased, after which both active and total t-PA levels again increased linearly with the plasma epinephrine concentration, but at twice the rate observed with epinephrine infusion (0.131 +/- 0.005 and 0.147 +/- 0.005 pmol/ng, respectively). The t-PA level in blood was directly proportional to the plasma epinephrine concentration during both exercise and epinephrine infusion, suggesting that epinephrine release during exercise stimulates t-PA secretion. In these healthy subjects, active plasminogen activator inhibitor type 1 and t-PA/PAI-1 complex levels were low (41 +/- 11 and 21 +/- 5 pmol/liter, respectively) and did not change significantly during exercise or epinephrine infusion. It is concluded that approximately 50% of the increase in t-PA during exercise is due to stimulated release of t-PA by epinephrine.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K. W. Lee and G. Y. H. Lip Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392. [Abstract] [Full Text] [PDF]

				A. W. Gardner and L. A. Killewich Association Between Physical Activity and Endogenous Fibrinolysis in Peripheral Arterial Disease: A Cross-sectional Study Angiology, July 1, 2002; 53(4): 367 - 374. [Abstract] [PDF]

				B. Venugopal, R. Sharon, R. Abramovitz, A. Khasin, and R. Miskin Plasminogen activator inhibitor-1 in cardiovascular cells: rapid induction after injecting mice with kainate or adrenergic agents Cardiovasc Res, February 1, 2001; 49(2): 476 - 483. [Abstract] [Full Text] [PDF]

				N. J. Brown, K.-S. Kim, Y.-Q. Chen, L. S. Blevins, J. H. Nadeau, S. G. Meranze, and D. E. Vaughan Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 336 - 344. [Abstract] [Full Text]

				N. J. Brown, M. Agirbasli, and D. E. Vaughan Comparative Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Antagonism on Plasma Fibrinolytic Balance in Humans Hypertension, August 1, 1999; 34(2): 285 - 290. [Abstract] [Full Text] [PDF]

				N. J. Brown, J. V. Gainer, C. M. Stein, and D. E. Vaughan Bradykinin Stimulates Tissue Plasminogen Activator Release in Human Vasculature Hypertension, June 1, 1999; 33(6): 1431 - 1435. [Abstract] [Full Text] [PDF]

				C. A. DeSouza, P. P. Jones, and D. R. Seals Physical Activity Status and Adverse Age-Related Differences in Coagulation and Fibrinolytic Factors in Women Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 362 - 368. [Abstract] [Full Text] [PDF]

				C. A. Desouza, D. R. Dengel, M. A. Rogers, K. Cox, and R. F. Macko Fibrinolytic responses to acute physical activity in older hypertensive men J Appl Physiol, June 1, 1997; 82(6): 1765 - 1770. [Abstract] [Full Text] [PDF]

				T. v. d. Poll, M. Levi, M. Dentener, P. M. Jansen, S. M. Coyle, C. C. Braxton, W. A. Buurman, C. E. Hack, J. W. t. Cate, and S. F. Lowry Epinephrine Exerts Anticoagulant Effects during Human Endotoxemia J. Exp. Med., March 17, 1997; 185(6): 1143 - 1148. [Abstract] [Full Text] [PDF]

				R. J. Parmer, M. Mahata, S. Mahata, M. T. Sebald, D. T. O'Connor, and L. A. Miles Tissue Plasminogen Activator (t-PA) Is Targeted to the Regulated Secretory Pathway. CATECHOLAMINE STORAGE VESICLES AS A RESERVOIR FOR THE RAPID RELEASE OF t-PA J. Biol. Chem., January 17, 1997; 272(3): 1976 - 1982. [Abstract] [Full Text] [PDF]

				I. Seljeflot, A. Moan, S. Kjeldsen, E. Sandvik, and H. Arnesen Effect of Angiotensin II Receptor Blockade on Fibrinolysis During Acute Hyperinsulinemia in Patients With Essential Hypertension Hypertension, June 1, 1996; 27(6): 1299 - 1304. [Abstract] [Full Text]

				C. A. DeSouza, D. R. Dengel, M. A. Rogers, K. Cox, and R. F. Macko The Fibrinolytic System Is Not Impaired in Older Men With Hypertension Hypertension, May 1, 1996; 27(5): 1053 - 1058. [Abstract] [Full Text]

				W. L. Chandler, W. C. Levy, and J. R. Stratton The Circulatory Regulation of TPA and UPA Secretion, Clearance, and Inhibition During Exercise and During the Infusion of Isoproterenol and Phenylephrine Circulation, November 15, 1995; 92(10): 2984 - 2994. [Abstract] [Full Text]

				A.B. Bridges, M. McLaren, and J.J.F. Belch A Comparative Study of Captopril and Enalapril on Endothelial Cell Function in Congestive Heart Failure Patients Angiology, September 1, 1995; 46(9): 811 - 817. [Abstract] [PDF]